A carregar...
Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
Endocrine therapy is a recognised option in the treatment of chemo-resistant ovarian cancer. We conducted a nonrandomised phase II evaluation of combination endocrine therapy with tamoxifen and goserelin in patients with advanced ovarian cancer that had recurred following chemotherapy. In total, 26...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361624/ https://ncbi.nlm.nih.gov/pubmed/16222310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602752 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|